How many insider declarations has Deep Track Biotechnology Master Fund, Ltd. filed?

Deep Track Biotechnology Master Fund, Ltd. has filed 4 public insider declarations with SEC (Form 4).

What is Deep Track Biotechnology Master Fund, Ltd.'s role?

Deep Track Biotechnology Master Fund, Ltd.'s reported role is not specified by the regulator across the filings.

Which companies does Deep Track Biotechnology Master Fund, Ltd. report trades for?

Deep Track Biotechnology Master Fund, Ltd. reports trades for 3 companies, including Dynavax Technologies CORP.

What is Deep Track Biotechnology Master Fund, Ltd.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 10.4M€.

← Executives ★ Sign in to follow

DT

Deep Track Biotechnology Master Fund, Ltd.

·SEC (Form 4)

Dynavax Technologies CORP LB PHARMACEUTICALS INC Attovia Therapeutics, Inc.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€10m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the full record of transactions filed by Deep Track Biotechnology Master Fund, Ltd.. Officer active across 3 companies, notably Dynavax Technologies CORP. In total, 4 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €10.4m. History available since 21 August 2025. The latest transaction was filed on 21 August 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Deep Track Biotechnology Master Fund, Ltd.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Dynavax Technologies CORP (US)LB PHARMACEUTICALS INC (US)Attovia Therapeutics, Inc. (US)

Declarations4 total

●

Deep Track Biotechnology Master Fund, Ltd.

10% OwnerExecutives6 Aug 2026Attovia Therapeutics, Inc.

0SEC ↗

1,957,138 sharesCommon StockSEC:0001193125-26-342487:0

●

Deep Track Biotechnology Master Fund, Ltd.

Executives10 Feb 2026Dynavax Technologies CORP

2SEC ↗

15,726,349 sharesCommon Stock, par value $0.001 per shareSEC:0001193125-26-046675:0

●

Deep Track Biotechnology Master Fund, Ltd.

Executives12 Sept 2025LB PHARMACEUTICALS INC

2SEC ↗

686,138 sharesCommon StockSEC:0002015536-25-000007:0

▼

Deep Track Biotechnology Master Fund, Ltd.

Executives21 Aug 2025Dynavax Technologies CORP

$12M10SEC ↗

1,094,994 shares@ US$11.03100.0% of flowCommon Stock, par value $0.001 per shareSEC:0000950170-25-111070:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

DT

Deep Track Biotechnology Master Fund, Ltd.

·SEC (Form 4)

Dynavax Technologies CORP LB PHARMACEUTICALS INC Attovia Therapeutics, Inc.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€10m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the full record of transactions filed by Deep Track Biotechnology Master Fund, Ltd.. Officer active across 3 companies, notably Dynavax Technologies CORP. In total, 4 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €10.4m. History available since 21 August 2025. The latest transaction was filed on 21 August 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.